Founded in 2011 by overseas returnees, LIDE’s founding vision was to leverage the latest technological advancements to bring to life the promise of personalized precision medicine. 11 years later, we are operating at the forefront of personalized oncology. Our proprietary K Cell and MiniPDX technologies are delivering individualized therapies to patients all over China. We strive to bring this worldwide over the next decade.
Vision: Maximize patient life with technology.
Mission: Ensure all patients benefit from personalized precision medical service.
Goal: Be a partner to doctors and health companies in finding the most effective therapy for each individual patient.
Connect with us to stay up to date on the latest news and innovations: